title: ANOS1: a unified nomenclature for Kallmann syndrome 1 gene (KAL1) and anosmin-1.
abstract: It is accepted that confusion regarding the description of genetic variants occurs when researchers do not use standard nomenclature. The Human Genome Organization Gene Nomenclature Committee contacted a panel of consultants, all working on the KAL1 gene, to propose an update of the nomenclature of the gene, as there was a convention in the literature of using the 'KAL1' symbol, when referring to the gene, but using the name 'anosmin-1' when referring to the protein. The new name, ANOS1, reflects protein name and is more transferrable across species.
authors.forename: Fernando
authors.initials: F
authors.lastname: de Castro
authors.forename: Ruth
authors.initials: R
authors.lastname: Seal
authors.forename: Roberto
authors.initials: R
authors.lastname: Maggi
mesh_terms: D000818:Animals; D016326:Extracellular Matrix Proteins / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D017436:Kallmann Syndrome / Q000235:genetics*; D009419:Nerve Tissue Proteins / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D009626:Terminology as Topic
chemical_list: C076266:ANOS1 protein, human; D016326:Extracellular Matrix Proteins; D009419:Nerve Tissue Proteins
keywords: : Kallmann; ANOS1; KAL1; anosmin-1; gene; nomenclature